Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Breaking Live 3 publishers covering this story in the last 6 hours

21m ago Awiqli Weekly Insulin Approved for Kids 10 and Up, but Child Data Come From One 18-Patient Dosing Study
2h ago Could AI Kill Superbugs? Company Says AI-Designed Phages Given to First Patient, but Outcome Remains Unknown
4h ago Biotech firm Rakuten Medical wants to bring its novel 'lightsaber' cancer cure to the U.S.

Vaccine advocate, on science, truth, and why he’s not a fan of the latest COVID boosters

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

The Philadelphia Inquirer · Nov 10, 2022

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday

Gainers

Benzinga · Nov 8, 2022

Dow Surges 400 Points; Crude Oil Down 1%

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Benzinga · Nov 7, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Benzinga · Nov 7, 2022

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Benzinga · Nov 7, 2022

US Stocks Mixed; Dow Rises Over 50 Points

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Benzinga · Nov 7, 2022

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

StockNews.com · Nov 7, 2022

Read news from The Economist, FT, and more,
with one subscription

High levels of cancer-causing chemical detected in dry shampoo, study finds

Benzene is a chemical which can raise the risk of some cancers after long-term exposure

The Independent UK · Nov 7, 2022

2 Stocks You Can Count on for Reliable Dividends

The Fed announced its fourth consecutive 75-bps rate hike this week. However, the Fed's aggression is expected to shrink eventually. Amid rampant market volatility, investor sentiment toward dividend stocks is robust. Therefore, fundamentally sound stocks Pfizer (PFE) and Caledonia Mining (CMCL) could be solid picks for a steady income stream.…

StockNews.com · Nov 4, 2022

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

StockNews.com · Nov 4, 2022

Death in CRISPR gene therapy study sparks search for answers

The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him

The Independent UK · Nov 4, 2022

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

The Independent UK · Nov 4, 2022

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Benzinga · Nov 4, 2022

Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Benzinga · Nov 3, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Nov 3, 2022

Colorado could become 2nd state to decriminalize mushrooms

Colorado voters are set to decide whether to decriminalize psychedelic mushrooms for those 21 and older and create state-regulated “healing centers” where participants can experience the drug

Tribune News Service · Nov 3, 2022

Biden ponders marijuana moves as states forge ahead

WASHINGTON — Five states will vote next week on whether to join the 21 states and territories that have legalized recreational marijuana for adults. But the federal government is still stuck on whether to remove the plant from Schedule I of the federal drug code — a category reserved for…

Reason · Nov 2, 2022

The Lincoln Project Demonstrates How Anti-Trump Fixation Can Lead to Lousy Policy

Reflexive opposition to the 45th president was terrible for Covid policy and basic ethics.

Inverse · Nov 2, 2022

Can you stuff a turkey? Science reveals how to prep this ancient holiday meal

Inverse speaks to a food scientist about whether you can — and should — stuff a turkey and how to stay food safe this holiday season.

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call · Nov 2, 2022

Biden ponders marijuana moves as states forge ahead - Roll Call

The U.S. policy debate has focused on whether more research is needed on potential benefits and harms of marijuana.

Tribune News Service · Nov 2, 2022

Despite Katie Couric’s advice, doctors say ultrasound breast exams may not be needed

When Katie Couric shared the news of her breast cancer diagnosis, the former co-host of NBC’s “Today” show said she considered this new health challenge to be a teachable moment to encourage people to get needed cancer screenings.

Benzinga · Nov 1, 2022

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder

Specialty biopharma company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has entered into an evaluation and exclusive option agreement with Case Western Reserve University (CWRU)

Benzinga · Nov 1, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

Benzinga · Nov 1, 2022

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More

15 Global Psychedelics Executives To Keep An Eye On In 2022

The Independent UK · Nov 1, 2022

FDA advisers meet on racial disparities in pulse oximeters

The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S. regulators after recent studies suggest they don’t work as well for patients of color

Benzinga · Nov 1, 2022

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

1 … 238 239 240 241

Coverage From

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.